EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Maternal Serum Netrin-1 Levels in Pregnancies Complicated by Gestational Diabetes Mellitus

Busra Colak, Nergis Kender Erturk, Esra Kartal Golcuk, Burcu Dincgez, Anil Erturk

The European Research Journal · 2026-12-01 · 1376-1382

DOI: 10.18621/eurj.1288 ↗
AbstractBibliografische Angaben

Abstract

Objective: Gestational diabetes mellitus (GDM) is associated with metabolic and vascular disturbances, yet its underlying biological mechanisms remain incompletely understood. Netrin-1, a multifunctional protein involved in angiogenesis, inflammation, and endothelial homeostasis, has been implicated in metabolic disorders; however, clinical data in GDM are limited. This study aimed to evaluate maternal netrin-1 levels in pregnancies complicated by GDM and to assess their associations with clinical parameters. Methods: This prospective case-control study included 45 pregnant women with GDM and 80 healthy pregnant controls between 24 and 28 weeks of gestation. Serum netrin-1 concentrations were measured using enzyme-linked immunosorbent assay. Clinical characteristics, glycemic parameters, and pregnancy outcomes were recorded. Receiver operating characteristic (ROC) analysis assessed the discriminatory performance of netrin-1 for GDM, and correlation and multivariable regression analyses identified associations after adjustment for selected covariates. Results: Serum netrin-1 levels were significantly lower in the GDM group compared with controls (P < .001). Netrin-1 concentrations showed significant inverse correlations with fasting plasma glucose (r = −0.45; P = .002) and HbA1c (r = −0.62; P < .001). ROC analysis identified an optimal cutoff value of 0.09 ng/mL for discriminating GDM, yielding a sensitivity of 68.9% and a high specificity of 98.8% (AUC = 0.86), indicating good discriminative performance. In multivariable analysis adjusted for age, body mass index, and parity, log-transformed netrin-1 levels were associated with GDM (P < .001). Conclusions: Maternal netrin-1 levels are significantly reduced in pregnancies complicated by GDM and are closely associated with glycemic dysregulation. Netrin-1 may reflect underlying metabolic and vascular alterations and could be considered as a complementary biomarker rather than a standalone diagnostic tool in GDM.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →